The quantitative PCR results were consistent with the transcriptome results, showing that the expression of CCL2, CCL3, CCL5, and CXCL9, but not CCL17 or CCL22, was markedly higher in 1.5 mg/kg AAGL-treated tumor-bearing mouse livers than in those of control mice (Figure 2F). This evidence concerns the gene CXCL9 and neoplasm.